Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

fluorine F 18 FTC-146

A radioconjugate composed of the selective sigma-1 receptor (S1R) ligand FTC-146 labeled with the radionuclide fluorine F 18, with potential use as an imaging agent for S1R-expressing tumor cells upon positron emission tomography (PET)/computed tomography (CT). Upon administration, fluorine F 18 FTC-146 targets and selectively binds to S1R expressed on tumor cells. The S1R-expressing tumor cells can then be visualized using PET/CT. S1R, widely distributed in the central nervous system (CNS) and peripheral tissues, plays a key role in the modulation of ion channels and other neurotransmitter systems, and in restoring neuronal function. It is upregulated in inflammatory diseases and in a variety of cancers. 18F-FTC-146 shows excellent selectivity for the S1R over the sigma-2 receptor and vesicular acetylcholine transporter (VAChT).
Synonym:(18)F-FTC-146
18F-6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo[d]thiazol-2(3H)-one
Search NCI's Drug Dictionary